Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vera S. Chernonosova, Alexander A. Gostev, Yuriy A. Chesalov, Andrey A. Karpenko, Alexander M. Karaskov & Pavel P. Laktionov. (2019) Study of hemocompatibility and endothelial cell interaction of tecoflex-based electrospun vascular grafts. International Journal of Polymeric Materials and Polymeric Biomaterials 68:1-3, pages 34-43.
Read now
Read now
Jianguo Zhang & Nana Lan. (2018) Hirudin variants production by genetic engineered microbial factory. Biotechnology and Genetic Engineering Reviews 34:2, pages 261-280.
Read now
Read now
Articles from other publishers (38)
Stefano Benenati, Giovanni Luigi De Maria, Francesco Della Mora, Leonardo Portolan, Rafail Kotronias, Rajesh K. Kharbanda, Italo Porto & Adrian P. Banning. (2023) Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: Have we discarded bivalirudin too soon?. Cardiovascular Revascularization Medicine 57, pages 70-79.
Crossref
Crossref
Ana Novo de Oliveira, Andreimar Martins Soares & Saulo Luís Da Silva. (2023) Why to Study Peptides from Venomous and Poisonous Animals?. International Journal of Peptide Research and Therapeutics 29:5.
Crossref
Crossref
Yaowei Tong, Julaiti Rouzhahong, Wangtao Zhou, Rui Wang, Yuqiang Wang, Yucheng Ren, Ju Guo, Ying Li, Zhengkai Wang & Yunlin Song. (2023) Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study. The International Journal of Artificial Organs 46:3, pages 162-170.
Crossref
Crossref
Brittany Salter & Mark Crowther. (2022) A Historical Perspective on the Reversal of Anticoagulants. Seminars in Thrombosis and Hemostasis 48:08, pages 955-970.
Crossref
Crossref
Marco Heestermans, Géraldine Poenou, Hind Hamzeh-Cognasse, Fabrice Cognasse & Laurent Bertoletti. (2022) Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications. Cells 11:20, pages 3214.
Crossref
Crossref
Sasa Rajsic, Robert Breitkopf, Dragana Jadzic, Marina Popovic Krneta, Helmuth Tauber & Benedikt Treml. (2022) Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review. Journal of Clinical Medicine 11:17, pages 5147.
Crossref
Crossref
Roman M. Sniecinski, Vance G. Nielsen & Kenichi Tanaka. (2022) Searching for an Alternate Anticoagulant for Cardiopulmonary Bypass: Does Two Plus Two Equal Two?. Anesthesia & Analgesia 135:1, pages 49-51.
Crossref
Crossref
Jeremy Daugherty, Caroline Heyrend, Michael Profsky, Brent Kay, Christina VanderPluym, Eric R. Griffiths & Lindsay J. May. (2020) Time in Therapeutic Range for Bivalirudin Among Pediatric Ventricular Assist Device Recipients. ASAIO Journal 67:5, pages 588-593.
Crossref
Crossref
Donald J. AbrahamMimi L. Quan, Peter W. Glunz & Joseph M. Luettgen. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
45
.
Tomasz Urbanowicz, Anna Olasińska-Wiśniewska, Marcin Ligowski, Ewa Goszczyńska & Marek Jemielity. (2021) Bivalirudin resistance during heart transplantation surgery.. Transplantation Reports 6:1, pages 100072.
Crossref
Crossref
Andrea Montisci, Giancarlo Micheletto, Serena Sibilio, Francesco Donatelli, Maurizio Tespili, Carlo Banfi, Francesco Casilli, Daniele Cosseta, Antonio Miceli, Silvia Cirri & Federico Pappalardo. (2020) Impella 5.0 supported oncological surgery as bridge to LVAD. ESC Heart Failure 8:1, pages 167-170.
Crossref
Crossref
Sukhdeep Bhogal, Debabrata Mukherjee, Jayant Bagai, Huu T. Truong, Hemang B. Panchal, Ghulam Murtaza, Mustafa Zaman, Rajesh Sachdeva & Timir K. Paul. (2020) Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials. Cardiovascular & Hematological Disorders-Drug Targets 20:1, pages 3-15.
Crossref
Crossref
Yan K. Gernhofer, Dalia A. Banks, Eugene Golts & Victor Pretorius. (2020) Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series. Seminars in Thoracic and Cardiovascular Surgery 32:4, pages 763-769.
Crossref
Crossref
Rahman Shah, Samuel B. Latham, Jennifer M. Porta, Arshi Naz, Khalid Matin & Sunil V. Rao. (2019) Bivalirudin with a post‐procedure infusion versus heparin monotherapy for the prevention of stent thrombosis. Catheterization and Cardiovascular Interventions 94:2, pages 210-215.
Crossref
Crossref
Danny Eytan & Gail M. Annich. 2019. Pediatric Critical Care. Pediatric Critical Care
231
241
.
David Stepensky. (2018) Pharmacokinetics of Toxin-Derived Peptide Drugs. Toxins 10:11, pages 483.
Crossref
Crossref
Juan Kuang, Lan Li, Xiang Ma, Jihong Gan & Shubin Jiang. (2018) Efficacy and Safety of Bivalirudin Plus Half/Full Dose of Tirofiban in Patients Undergoing Emergency Percutaneous Coronary Intervention. International Journal of Pharmacology 14:4, pages 506-512.
Crossref
Crossref
Chenguang Li, Rende Xu, Yi Shen, Yuxiang Dai, Feng Zhang, Jianying Ma, Lei Ge, Juying Qian & Junbo Ge. (2018) Bivalirudin in percutaneous coronary intervention for chronic total occlusion: A single-center pilot study. Catheterization and Cardiovascular Interventions 91:4, pages 679-685.
Crossref
Crossref
Nilay K. Patel & Sammy Elmariah. 2018. Anticoagulation Therapy. Anticoagulation Therapy
197
216
.
Rahman Shah, Khalid Matin, Kelly C. Rogers & Sunil V. Rao. (2017) Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials. Catheterization and Cardiovascular Interventions 90:2, pages 196-204.
Crossref
Crossref
Heyang Wang, Zhenyang Liang, Yi Li, Bin Li, Junming Liu, Xueyi Hong, Xin Lu, Jiansheng Wu, Wei Zhao, Qiang Liu, Jian An, Linfeng Li, Fanli Pu, Qiang Ming & Yaling Han. (2017) Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population. Cardiovascular Therapeutics 35:3, pages e12251.
Crossref
Crossref
Ožbej Zupančič, Julia Anita Grießinger, Hung Thanh Lam & Andreas Bernkop-Schnürch. (2017) Storage Stability of Bivalirudin: Hydrophilic Versus Lipophilic Solutions. Journal of Pharmaceutical Sciences 106:5, pages 1322-1330.
Crossref
Crossref
Rahman Shah, Kelly C. Rogers, Agha J. Ahmed, Bryan J. King & Sunil V. Rao. (2016) Effect of Post–Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis. JACC: Cardiovascular Interventions 9:13, pages 1313-1320.
Crossref
Crossref
Zhuguo Liu, Zheng Yu, Yuanyuan Huang, Yan Zhang, Guozhu Han, Xian Li, Mingxin Dong, Shuo Yu, Yu Wang, Jie Hu, Huiqin Guo, Yuanguo Cheng, Li Lv & Qiuyun Dai. (2015) A novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity. Scientific Reports 5:1.
Crossref
Crossref
Roman M. Sniecinski & Jerrold H. Levy. (2015) Anticoagulation management associated with extracorporeal circulation. Best Practice & Research Clinical Anaesthesiology 29:2, pages 189-202.
Crossref
Crossref
J. Harenberg, V. A.-T. Hentschel, S. Du, S. Zolfaghari, R. Krämer, C. Weiss, B. K. Krämer & M. Wehling. (2017) Anticoagulation in patients with impaired renal function and with haemodialysis. Hämostaseologie 35:01, pages 77-83.
Crossref
Crossref
Marc Aldenkortt & Marc Licker. 2015. Perioperative Hemostasis. Perioperative Hemostasis
391
417
.
Lynne M. Sylvia, Linda Ordway, Duc T. Pham, David DeNofrio & Michael Kiernan. (2014) Bivalirudin for Treatment of LVAD Thrombosis. ASAIO Journal 60:6, pages 744-747.
Crossref
Crossref
Mehdi Ben Saida & Sami Guermazi. (2013) Thrombopénies induites par l’héparine. Revue Francophone des Laboratoires 2013:457, pages 51-59.
Crossref
Crossref
Anne M. Winkler & Christopher A. Tormey. (2013) Pathology Consultation on Monitoring Direct Thrombin Inhibitors and Overcoming Their Effects in Bleeding Patients. American Journal of Clinical Pathology 140:5, pages 610-622.
Crossref
Crossref
Barry S. Coller. (2012) Translating from the rivers of Babylon to the coronary bloodstream. Journal of Clinical Investigation 122:11, pages 4293-4299.
Crossref
Crossref
Ziad Sergie, Roxana Mehran & Gregg W. Stone. (2012) What is the optimal antithrombotic strategy in primary percutaneous coronary intervention?. Current Opinion in Cardiology 27:4, pages 361-367.
Crossref
Crossref
Falk Rohrbach, Maha I. Fatthalla, Tina Kupper, Bernd Pötzsch, Jens Müller, Michael Petersen, Erik B. Pedersen & Günter Mayer. (2012) Chemical Maturation of a Bivalent Aptamer by Single Domain Variation. ChemBioChem 13:5, pages 631-634.
Crossref
Crossref
Glenn M. LaMuraglia, Rabih Houbballah & Michael Laposata. (2012) The identification and management of heparin-induced thrombocytopenia in the vascular patient. Journal of Vascular Surgery 55:2, pages 562-570.
Crossref
Crossref
Linda Shore-Lesserson & Liza J. Enriquez. (2012) Hematological Issues in Cardiovascular Surgery Patients. ASA Refresher Courses in Anesthesiology 40:1, pages 129-135.
Crossref
Crossref
Roman M. Sniecinski & Wayne L. Chandler. (2011) Activation of the Hemostatic System During Cardiopulmonary Bypass. Anesthesia & Analgesia 113:6, pages 1319-1333.
Crossref
Crossref
John G.T. Augoustides. (2011) Update in Hematology: Heparin-Induced Thrombocytopenia and Bivalirudin. Journal of Cardiothoracic and Vascular Anesthesia 25:2, pages 371-375.
Crossref
Crossref
Dongmei Zhang, Zining Wang, Xia Zhao, Wei Lu, Jingkai Gu & Yimin Cui. (2011) Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects. Biological and Pharmaceutical Bulletin 34:12, pages 1841-1848.
Crossref
Crossref